Extendicare (EXE) Price Target Cut to C$8.00
Extendicare (TSE:EXE) had its price target cut by analysts at Royal Bank of Canada from C$8.50 to C$8.00 in a research note issued on Tuesday, November 13th. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 18.52% from the stock’s previous close.
Separately, TD Securities cut their price objective on shares of Extendicare from C$9.00 to C$8.50 in a research report on Monday, November 12th.
Shares of TSE EXE remained flat at $C$6.75 during mid-day trading on Tuesday. The stock had a trading volume of 139,900 shares, compared to its average volume of 199,231. The company has a debt-to-equity ratio of 407.66, a current ratio of 0.65 and a quick ratio of 0.56. Extendicare has a 12 month low of C$6.61 and a 12 month high of C$9.44.
In other news, Director Alan Roy Hibben acquired 3,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 14th. The shares were acquired at an average cost of C$7.16 per share, with a total value of C$25,060.00. Also, Director Michael Robert Guerriere bought 10,000 shares of the firm’s stock in a transaction on Monday, November 12th. The shares were bought at an average cost of C$7.36 per share, for a total transaction of C$73,600.00. Insiders have bought 14,950 shares of company stock worth $108,513 over the last ninety days.
Extendicare Inc provides care and services for seniors in Canada. The company offers long term care services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management and consulting services to third-party owners.
Featured Article: Why is the ex-dividend date different from the record date?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.